한국어 · English · 简体中文 · Русский · Bahasa Indonesia · ภาษาไทย · Tiếng Việt · 日本語

Approved ingredients

리스펙타(Respecta®)[프로바이오틱스 등 복합물](기능성원료인정제2019-26호)

리스펙타(Respecta®)[프로바이오틱스 등 복합물](기능성원료인정제2019-26호)

MFDS recognition no.제2019-26호
Approval routeIndividually approved (개별인정형) — only the approval holder may use this wording
Daily intake (as approved)124.0–124.0 mg

Approved wording (Korean original)

(국문) 질내 유익균 증식 및 유해균 억제에 도움을 줄 수 있음 (영문) May help to proliferate vaginal beneficial flora and to suppress pathogenic bacteria

Precautions (Korean original)

(1) 영·유아, 어린이, 임산부 및 수유부는 섭취에 주의 (2) 우유, 유제품 및 기타 제품에 대해 알레르기가 있는 사람은 섭취에 주의 (3) 이상사례 발생 시 섭취를 중단하고 전문가와 상담할 것
the FDA, EFSA or your national authorityRequirements differ by market. Confirm ingredient status and label wording with your own authority before importing.

Sourcing from Korea

Last synchronised: 2026-07-22

Approvals described here were issued by the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea and are valid in South Korea only. They are not health claims in your jurisdiction and have not been evaluated by the FDA, EFSA, or any other authority. This page reports regulatory facts and does not recommend any product.